JP7523198B2 - Information processing device, server, information processing method and program - Google Patents

Description

The present invention relates to an information processing device , a server, an information processing method, and a program.

Developments in information processing technology have also penetrated widely into medical institutions such as pharmacies that dispense and provide medicines, increasing convenience. For example, medical institutions have long known computers such as medical receipt computers that assist in the creation of medical receipts (medical fee statements), making it possible to create receipts without the need for advanced specialized knowledge or complex calculations. In recent years, systems that electronically manage patient information such as medication history have also become widespread.

Note that, in the past, the medical receipt computer and the system for managing medical history were separate computers in terms of hardware, but for example, Patent Document 1 discloses a pharmacy computer that has a medical receipt computer function and a medical history management function, and that effectively links the two functions.

JP 2011-118535 A

When dispensing medicine to a patient, prescription audits are conducted to check whether there are any suspicious points regarding issuing the medicine as is, taking into account the information written on the prescription, the patient's information, medical history, etc. In such prescription audits, clinical test values are sometimes referenced, which can give an understanding of the patient's illness or injury and the effects of the medicines they are taking. However, there are many clinical test values, and simply displaying the many input clinical test values makes it impossible to efficiently grasp the information on the intended illness or medicine. As a result, even if information such as clinical test values is displayed for prescription audits, it is not possible to efficiently find the necessary clinical test value information, making it impossible to quickly conduct appropriate prescription audits.

The present invention has been made in consideration of these circumstances, and aims to provide a display device and a program that display clinical test values that enable efficient understanding of information required for prescription audits of prescriptions prescribed to patients.

(1) A display device for displaying clinical test values, comprising: a grouping means for receiving drugs and clinical test values written on a prescription and grouping the clinical test values based on the relationship between the drugs and the clinical test values; and a display means for displaying the grouped clinical test values on a display unit in a manner that allows distinction between each group.

(2) A display device that displays the clinical test values described in (1), in which the grouping may involve classifying a single clinical test value into different groups for each drug.

(3) A display device that displays the clinical test values described in (1) or (2), in which the grouping is performed for each drug effect and drug side effect.

(4) A display device that displays a clinical test value according to (3), in which the grouping may result in classification of a clinical test value as a side effect of a drug when the value of the clinical test value is a predetermined value.

(5) A display device that displays clinical test values according to any one of (1) to (4), in which the display means displays, in response to receiving a selection of a drug, a clinical test value that has the relationship with the drug and a clinical test value that does not have the relationship with the drug.

(6) A display device for displaying a clinical test value according to any one of (1) to (5), in which the display means displays the clinical test value by distinguishing the location where the clinical test value was obtained.

(7) A program that causes a computer to execute a grouping step of accepting medications and clinical test values written on a prescription and grouping the clinical test values based on the relationship between the medications and the clinical test values, and a display step of displaying the grouped clinical test values on a display unit in a manner that allows them to be distinguished by group.

The selection of the drug column, prescription audit related information column, and crossover column may be made by accepting the selection of any one column to display specific information, and specific information may be displayed by selecting only the drug column, selecting only the prescription audit related information, selecting only the crossover column, selecting the drug column and the prescription audit related information column, selecting the drug column and the prescription audit related information column, selecting the prescription audit related information column and crossover column, or selecting the drug column, the prescription audit related information column, and the crossover column.

The present invention makes it possible to efficiently obtain information necessary for prescription audits of prescriptions prescribed to patients.

FIG. 1 is a diagram showing the configuration of a display system for displaying clinical test values. FIG. 1 is a diagram showing an overview of drug supply operations. FIG. 2 is a block diagram showing the functional configuration of a display device that displays clinical test values. FIG. 4 is a diagram showing a patient DB in the storage unit. FIG. 4 is a diagram showing a clinical test value DB in the storage unit. FIG. 4 is a diagram showing a package insert DB in the storage unit. FIG. 13 is a diagram showing an example of a display screen displayed on a display device that displays clinical test values. FIG. 13 is a diagram showing an example of a display screen displayed on a display device that displays clinical test values. 1 is a flowchart showing a process flow of a display system for displaying clinical test values. FIG. 2 is a block diagram showing the functional configuration of a display device that displays clinical test values. FIG. 4 is a diagram showing a patient DB in the storage unit. FIG. 13 is a diagram showing an example of a display screen displayed on a display device that displays clinical test values.

One embodiment of the present invention will be described below with reference to the drawings.

[First embodiment]
[Configuration of display system 100 for displaying clinical test values]
Referring to Figure 1, the display system 100 for displaying clinical test values of the present invention is composed of an administrator device 1, display devices 2a...2n for displaying clinical test values used by pharmacy staff, and a display 3 for informing patients of the progress of drug provision work.

The display devices 2a to 2n that display clinical test results are terminal devices used by the personnel in charge of each task constituting the medicine supply business.
Here, referring to FIG. 2(1), the drug provision work is composed of a series of steps, such as receiving a prescription from a patient at the counter, dispensing a drug according to the prescription, and providing the drug to the patient at the counter if the dispensing is deemed appropriate in the final audit. Such a drug provision work can be composed of the tasks shown in FIG. 2(2), namely, "reception", "medical history confirmation", "prescription audit", "collection of patient information", "dispensing design", "explanation of medication", "dispensing decision", "dispensing", "final audit", and "drug delivery accounting". Some of these tasks can be carried out independently of each other, and in this embodiment, each of these tasks is divided into multiple personnel. For example, of the tasks constituting the drug provision work, pharmacist A is in charge of "reception", "collection of patient information", "dispensing", and "drug delivery accounting", pharmacist B is in charge of "medical history confirmation", "prescription audit", "dispensing design", "explanation of medication", and "dispensing decision", and pharmacist C is in charge of "final audit".
In this embodiment, for example, the display device 2a that displays the clinical test values is used by pharmacist A, the display device 2b that displays the clinical test values is used by pharmacist B, and the display device 2c that displays the clinical test values is used by pharmacist C. Of course, the display devices 2a to 2n that display the clinical test values may not only be used by one person in charge, but may also be shared by multiple people in charge. Since the configurations of the display devices 2a to 2n that display the clinical test values are basically the same, hereinafter they may be simply referred to as "display devices 2 that display clinical test values."

The administrator device 1 is a terminal device used by an administrator who manages each person in charge, and has administrator authority to expand, change, and restrict the functions of the display device 2 that displays clinical test values. It is a general-purpose personal computer that has an input unit realized by a keyboard, touch panel, etc., and a display unit with a display, in addition to a control unit that performs various calculation processes and a memory unit that stores various information.

The display device 2 that displays the clinical test values is intended to provide multifaceted support for the work of pharmacies, and is realized by a general-purpose personal computer, like the manager device 1. Various programs are installed on the display device 2 that displays such clinical test values, and the control unit operates according to these programs to perform a receipt function, a medical history management function, a work allocation function, and a clinical test value display function in a "prescription audit." Note that clinical test values are referenced when grasping the patient's injury or illness condition and the degree of the effect of a drug, and refer to values that qualitatively or quantitatively measure components, cells, etc. contained in the patient, and are referenced in pharmacies to grasp whether the drug is sufficiently effective and whether any side effects of the drug are occurring in a "prescription audit."
The administrator device 1 and the display device 2 for displaying clinical test results are connected via a specified network line and cooperate with each other to support the provision of medicines to patients.

The display 3 is positioned facing the patient visiting the pharmacy and displays to the patient the progress of the drug provision work. The display 3 is communicatively connected to the administrator device 1 and/or the display device 2 that displays clinical test values, and displays the progress according to instructions from the administrator device 1 and/or the display device 2 that displays clinical test values.

[Functional configuration of the display device 2 that displays clinical test values]
Next, the configuration of the display device 2 that displays the clinical test values will be described with reference to Fig. 3. The display device 2 that displays the clinical test values has a receiving means 211, an extracting means 212, a grouping means 213, and a display means 214 in the control unit 21, and has a patient DB 221, a clinical test value DB 222, and a package insert DB 223 in one area of the storage unit 22.

The reception unit 211 receives the contents of a prescription and the clinical test results of the patient at a particular visit to the hospital, and stores the prescription contents and the clinical test results in the patient DB 221 in association with the patient ID.
Here, prescription contents refers to information about the contents written on the prescription and information generated when the prescription is accepted, such as patient-specific information such as the patient's name, the prescribed drug indicating the prescribed drug, the acceptance date indicating the date the prescription was accepted by the pharmacy, and the first dose indicating whether the drug written on the prescription has been prescribed for the patient for the first time.
In addition, the clinical test values are stored including, for example, biopsies regarding the patient's condition, such as blood pressure and pulse rate, as well as specimen tests of components and cells present in the patient by analyzing samples taken from the patient, such as blood glucose level, red blood cell count, urinary protein, and γ-GTP.
The prescription contents and clinical test values accepted by the accepting means 211 are used when the extracting means 212 extracts the patient's past prescription contents and clinical test values, and when the grouping means 213 groups the clinical test values, as described below.

The extraction means 212 extracts from the patient DB the past prescription contents and the types and values of clinical test values associated with the patient ID of the patient who received the prescription. The extraction means 212 also extracts from the clinical test value DB 222 the relationship between the drugs included in the received prescription contents and the clinical test values based on the received prescription contents and the types and values of the clinical test values.

Also, referring to FIG. 4, the patient DB 221 will be described. The patient DB 221 is a DB that stores the prescription contents and clinical test values received at the pharmacy, and stores the prescription contents and clinical test values received by the reception means 211 in association with a patient ID. The patient DB 221 is configured to have a "patient ID" that stores information identifying the patient, a "patient name" that stores the patient's name, a "reception date" that stores the date on which the prescription was received, a "medicine" that stores the prescribed drug, which is the received prescription content, a "clinical test value item" that stores the type of the received clinical test value, and a "clinical test value" that stores the value of the received clinical test value. The value of the "clinical test value" stores a quantitative value such as a specific number, as well as a qualitative value indicating the presence or absence of the clinical test value. For example, a quantitative value of 95 mgHG, which is a specific number, is stored for a clinical test value called systolic blood pressure, and a qualitative value such as "yes" or "no" is stored for a clinical test value called urinary protein, which indicates that the clinical test value has been detected. In addition to this information, the patient DB 221 may also include information regarding other patient personal information, medication information, and clinical test value information.

The clinical test value DB 222 will be described with reference to Fig. 5. The clinical test value DB 222 is a DB having a relationship table that stores the relationship between drugs and types and values of clinical test values, and a normal value table that stores normal values of clinical test values. The relationship table stores "drug" which is information about the drug, "clinical test value item" which stores the type of clinical test value, "clinical test value" which stores the value of the clinical test value, and "relationship" which is the relationship between the drug and the type and value of the clinical test value. The normal value table stores clinical test values and their normal values.
In addition to such information, the clinical test value DB 222 may be configured to include other information related to the relationship between the drug and the clinical test value. The normal value table may be configured to have different normal values depending on gender, age, etc.
Here, "relationship" specifically refers to information indicating what relationship the clinical test value has with respect to a drug. For example, information is stored that a clinical test value of systolic blood pressure for a drug called antihypertensive drug A has a relationship of "drug effect." Also, for example, information is stored that a clinical test value of γ-GTP for a drug called antihypertensive drug A has a relationship of "drug side effect." Also, such relationships are not limited to drug effects and side effects, and there may be three or more relationships. For example, a clinical test value of pulse rate for a drug called antihypertensive drug A may have a relationship such as "drug effect (off-label)." Here, off-label refers to use for a purpose that is not included in the approved content of the drug.
Furthermore, the "relationship" may be configured such that the relationship changes depending on the value even for the same drug and type of clinical test value. For example, information is stored that the clinical test value of systolic blood pressure for a drug called antihypertensive drug A has a relationship of "drug effect," while information is also stored that if the value of systolic blood pressure is "100 mgHG or less," the relationship is "drug side effect." In this case, for antihypertensive drug A, if the systolic blood pressure exceeds 100 mgHG, the systolic blood pressure is classified only as "drug effect," but if the systolic blood pressure is 100 mgHG or less, the systolic blood pressure is classified as both "drug effect" and "drug side effect."

The package insert DB 223 will be described with reference to FIG. 6. The package insert DB 223 stores data on the package insert of a drug in association with the drug for each item. The package insert is a product information document for doctors and medical institution personnel that describes the drug name, precautions for use, product specifications, and other important information about the drug. In addition to the drug name, the package insert DB 223 stores information such as efficacy and effects indicating indications and dosage, precautions for use, and side effects, in correspondence with the items of the package insert. Although not shown in the figure, in addition to the information described in the package insert, items other than the package insert, such as long-term administration check drugs and high-risk drugs, may also be provided.

The grouping means 213 groups the clinical test values for each drug based on the relationship between the drug and the clinical test values extracted by the extraction means 212 .
Here, the reason why the grouping means 213 groups the clinical test values by drug will be described. When dispensing to a patient, in order to perform prescription auditing to check whether there is anything suspicious about issuing the drug as is based on the description of the prescription, the patient information, the medical history, etc., clinical test values that can grasp the patient's condition of injury or illness and the influence of the drug being taken are sometimes referred to. However, there are many clinical test values, and even if all the clinical test values from which information was obtained are displayed during prescription auditing, some of them are not influenced by the prescribed drug. In this way, if clinical test values that are not influenced by taking the drug are displayed, there is a risk that the clinical test values that should be grasped during prescription auditing cannot be grasped, or it may take time to grasp them. In addition, even if the clinical test values are influenced by taking the drug, if the clinical test values related to the effect of the drug and the clinical test values related to the side effects of the drug are mixed, the pharmacist cannot intuitively grasp the clinical test values during prescription auditing.
Therefore, the display device 2 for displaying the clinical test values displays the clinical test values that are affected by drugs, and displays the clinical test values in groups based on the relationship between the drug and the clinical test value for each drug.

Specifically, the grouping means 213 will be described by way of example of a process of grouping clinical test values for each drug based on the relationship between the drug and the clinical test value. For example, in this embodiment, the grouping means 213 groups the clinical test values of Patient A, which are the systolic blood pressure, pulse rate, γ-GTP, and blood glucose level, for Drug A, as the systolic blood pressure, diastolic blood pressure, and pulse rate as "drug effects". In addition, since Patient A has a systolic blood pressure of 90 mgHG, for Drug A, the grouping means 213 groups the systolic blood pressure and γ-GTP as "drug side effects".
Here, the systolic blood pressure, diastolic blood pressure, and pulse rate are grouped together as the "effect of the drug," but since the relationship between drug A and pulse rate is the "effect of the drug (off-label)," the systolic blood pressure and diastolic blood pressure may be grouped together as the "effect of the drug," and pulse rate may be grouped together as the "effect of the drug (off-label)," in a different group from the "effect of the drug."

The display means 214 generates display screen data configured to group the clinical test values and distinguish each clinical test value according to the relationship between the drug and the clinical test value based on the prescription contents and clinical test values accepted by the accepting means 211 and the clinical test values and relationships extracted by the extracting means 212, and displays the data on the display unit 24. The display means 214 also displays the period of drug intake based on the accepted prescription contents and the past prescription contents extracted by the extracting means 212. In addition, in response to accepting the selection of a drug displayed from the input unit 23, the display means 214 generates display screen data configured to limit the display to the clinical test values related to the drug, group the clinical test values, and distinguish each clinical test value according to the relationship between the drug and the clinical test value, and displays the data on the display unit 24.

Now, the display screen data displayed by the display means 214 on the display unit 24 will be described with reference to FIG. 7. FIG. 7 is a diagram showing that the display screen data generated by the display means 214 is displayed on the display unit 24, and the displayed screen is an example of a display screen that is displayed when pharmacist "Azuma Taro" selects "Drug A" when performing a prescription audit of a prescription for patient "A." The pharmacist refers to this screen to perform a prescription audit and confirm the prescription contents based on the information written on the prescription, the patient information, medication history, and clinical test results.

The display area V1 is a screen illustrating the period during which the prescribed medicine is taken. In the display area V1, the date is displayed on the horizontal axis, and the contents of the prescription accepted by the accepting means 211 and the medicines prescribed in the past are displayed on the vertical axis. A bar indicating the period during which the medicine was prescribed is displayed in the center. For example, B1 indicates that the medicine B has been prescribed for 7 days from May 1st. In addition, when the period during which the medicine is taken in a certain prescription overlaps with the period during which the medicine is taken in the prescription before and after the prescription, the bars are shifted up and down so that the bars do not overlap, and a bar indicating the overlap is displayed under the period during which the periods overlap. For example, as in B2, the bar indicating the medicine A for 21 days prescribed on April 16th is shifted up, and the bar indicating the medicine A for 30 days prescribed on May 1st is shifted down, and a bar indicating the overlap is displayed in the period from May 1st to May 6th.
When a drug is selected and displayed in the display area V1, clinical test values related to the selected drug are displayed in a display area V2, which will be described later.

In the display areas V2, V3, and V4, the clinical test values of the prescribed drugs are displayed in a distinguishable manner. In V2, V3, and V4 in Fig. 7, the selection of the drug A is accepted, and the clinical test values related to the drug A are displayed in a distinguishable manner according to their respective relationships.
In the display area V2, clinical test values whose relationship with drug A is "drug effect" are displayed. For example, in the display area V2, systolic blood pressure, diastolic blood pressure, and pulse rate whose relationship with drug A is "drug effect" are displayed as the same group. In addition, in the display area V3, clinical test values whose relationship with drug A is "drug side effects" are displayed. For example, systolic blood pressure, γ-GTP, and urinary protein whose relationship with drug A is "drug side effects" are displayed as the same group. Note that the systolic blood pressure displayed in "drug side effects" is displayed in "drug side effects" because the value on May 1st was 100 or less, but if there is no time when the systolic blood pressure value is 100 or less, the systolic blood pressure will not be displayed in "drug side effects".

Display area V4 accepts the selection of drug A and displays laboratory test values that are not related to drug A. For example, fasting blood glucose and HbA1C, which are not affected by drug A, are displayed in the same group.

Graphs showing changes in each clinical test value are displayed in display areas V2, V3, and V4. The horizontal axis of the graph shows the date, and the vertical axis shows the clinical test value. The normal value range showing normal values of the clinical test value is shown in the center of the graph, and quantitative clinical test values are displayed as a line diagram. Qualitative clinical test values are displayed as +- to indicate the presence or absence of the value.
Here, the date on the horizontal axis can be changed by pressing the scale enlargement or reduction button, and can be changed from days to weeks, months, etc. Also, the clinical test values on the vertical axis are displayed by extracting normal values of the clinical test values to be displayed from the clinical test value DB 222, and adjusting the scale units of the vertical axis so that the normal ranges of the respective clinical test values are the same. For example, the systolic blood pressure, diastolic blood pressure, and pulse rate displayed in V3 are 100-129, 60-79, and 50-90, respectively, and the values of the scale (lower limit of the scale, interval between the scales, and upper limit of the scale) on the vertical axis are adjusted to be different for each clinical test value so that the respective normal value ranges are displayed as normal value ranges in the graph.

The necessity for the vertical axis to display the normal value ranges in the same way will be explained with reference to the simplified diagram of FIG.
In V5 of Fig. 8, the systolic blood pressure and the diastolic blood pressure are displayed, but the scales of the respective clinical test values are displayed to be the same, and the normal value ranges are displayed differently. However, when displayed in this way, a problem occurs in that it is difficult to intuitively understand which clinical test value corresponds to which line graph, and this problem becomes more difficult to intuitively understand as the number of types of clinical test values increases.
Therefore, in the display device 2 that displays the clinical test values, the scale values are adjusted so that the normal value ranges are the same for different types of clinical test values.
The display in FIG. 7 and the display in FIG. 8 may be switched between each other in response to a user's selection.

[Operation of the display device 2 for displaying clinical test values]
Next, the operation of the display device 2 that displays the clinical test values will be described with reference to FIG.
First, the reception means 211 receives prescription contents and/or clinical test values (step S1). Then, the reception means 211 associates the received prescription contents and/or clinical test values with a patient ID and stores them in the patient DB 221 (step S2). Then, the extraction means 212 extracts information on past prescription contents and clinical test values, and the relationship between drugs and clinical test values, etc., required for generating display image data (step S3). Then, the grouping means 213 groups the clinical test values for each drug based on the relationship between the drug and the clinical test values extracted by the extraction means 212 (step S4). Then, the display means 214 generates data for a display screen configured to group the clinical test values and distinguish each clinical test value according to the relationship between the drug and the clinical test value based on the prescription contents and clinical test values received by the reception means 211 and the clinical test values and relationships extracted by the extraction means 212 (step S5). Then, the display means 214 outputs the generated data for the display screen to the display unit 24 (step S6).

Then, the reception means 211 receives the selection of the drug (step S7). Then, in response to the reception means 211 receiving the selection of the drug, the display means 214 generates data for a display screen limited to the clinical test values related to the selected drug (step S8). Then, the display means 214 outputs the generated display screen data to the display unit 24 (step S9).

As described above, in this embodiment, clinical test values that are not affected by the prescribed drug are not displayed, and only clinical test values related to the prescribed drug are displayed. This allows the pharmacist to properly understand the effectiveness and side effects of the prescribed drug, and efficiently grasp the information necessary for prescription audits of prescriptions prescribed to patients.

In addition, in this embodiment, clinical test values that are not affected by the prescribed drug are not displayed, and only clinical test values related to the prescribed drug are displayed, so that pharmacists can properly understand the effectiveness and side effects of the prescribed drug, and can efficiently understand the information necessary for prescription audits of prescriptions prescribed to patients.

In addition, in this embodiment, among the prescribed drugs, clinical test values that are not affected by the drug selected by the pharmacist are not displayed, and only clinical test values related to the drug selected by the pharmacist are displayed. Therefore, the pharmacist can properly understand which of the prescribed drugs affects the clinical test values and is causing efficacy or side effects, and can efficiently grasp the information necessary for prescription audits of prescriptions prescribed to patients.

In addition, in this embodiment, clinical test values that are not affected by the prescribed medication are not displayed, and only clinical test values related to the prescribed medication are displayed, and the relationships are displayed differently depending on the values of the clinical test values. This allows the pharmacist to intuitively grasp the meaning of the displayed clinical test values for the prescribed medication, and efficiently grasp the information necessary for prescription audits of prescriptions prescribed to patients.

[Second embodiment]
In the first embodiment, the display device 2 has, in the control unit 21, a reception means 211, an extraction means 212, a grouping means 213, and a display means 214, and in one area of the memory unit 22, a patient DB 221, a clinical test value DB 222, and a package insert DB 223.
On the other hand, in this embodiment, as shown in FIG. 10, the control unit 21 has a reception means 211a, an extraction means 212, a grouping means 213, a display means 214a, and a display switching reception means 215, and one area of the memory unit 22 has a patient DB 221a, a clinical test value DB 222, and a package insert DB 223.
The functional configuration of this embodiment will be described below, with the description of the same functions as those of the first embodiment being omitted.

The reception means 211a receives the contents of the prescription at the time of a specific patient visit, the patient's clinical test values, and the location where the clinical test values were obtained, and stores the prescription contents, clinical test values, and the location where the clinical test values were obtained in the patient DB 221a in association with the patient ID.
The receiving means 211a receives the location where the clinical test values were obtained, in a manner that distinguishes whether the entity that obtained the clinical test values was a medical institution or a patient, etc., and if the entity that obtained the clinical test values was a medical institution, what type of medical institution it was.

Furthermore, referring to FIG. 11, the patient DB 221a will be described. The patient DB 221a is a DB that stores the prescription contents and clinical test values received at the pharmacy, and stores the prescription contents and clinical test values received by the reception means 211 in association with a patient ID. The patient DB 221a is configured to have a "patient ID" that stores information identifying the patient, a "patient name" that stores the patient's name, a "reception date" that stores the date the prescription was received, a "medicine" that stores the prescribed medicine that is the received prescription contents, a "laboratory test value item" that stores the type of the received clinical test value, and a "laboratory test value" that stores the value of the received clinical test value, as well as a "location of acquisition of the clinical test."

Returning to FIG. 10, the display switching receiving means 215 receives the display method of the clinical test values, and displays on the display unit 24 the clinical test values according to the received display method.
Specifically, the display switching receiving means 215 receives the display method of the clinical test values. The display method of the clinical test values is a display method as to whether or not to display the clinical test values with distinction based on the location where the clinical test values were obtained. When displaying the clinical test values with distinction, the method of distinction is selected. The display method of the clinical test values receives a selection of, for example, "Do not distinguish", "Distinguish and change display depending on location", "Distinguish and display only medical institutions", or "Distinguish and display only home".

The display means 214a generates data for a display screen configured to group the clinical test values and distinguish each clinical test value according to the relationship between the drug and the clinical test value based on the prescription contents and clinical test values accepted by the accepting means 211 and the clinical test values and relationships extracted by the extracting means 212, and displays the data on the display unit 24. The display means 214a displays the clinical test values according to the display method accepted by the display switching accepting means 215.

Here, the display screen data displayed on the display unit 24 by the display means 214a will be described with reference to FIG. 12. FIG. 12 is a diagram showing the display screen data generated by the display means 214a being displayed on the display unit 24. Note that points common to the first embodiment will be described briefly.

FIG. 12(1) shows display data generated by the display means 214a when the display switch receiving means 215 receives "no distinction".
In the display region V2a, since "no distinction" has been selected, the line L1 is displayed without distinguishing the location where the clinical test value of the systolic blood pressure was obtained.
FIG. 12(2) shows display data generated by the display means 214a when the display switching reception means 215 receives "distinguish/change display depending on location."
In the display area V2a, because “Differentiate/change display by location” was selected, the clinical test value of systolic blood pressure obtained at Clinic Alpha is displayed as line L2, and the clinical test value of systolic blood pressure obtained at home is displayed as line L3.
FIG. 12(3) shows display data generated by the display means 214a when the display switching reception means 215 receives "distinguish and display only medical institutions."
In the display area V2a, because "distinguish and display only medical institutions" has been selected, the clinical test value of systolic blood pressure obtained at Clinic α is displayed as line L4. Note that the clinical test value of systolic blood pressure obtained at home is excluded from line L4, but only a mark is displayed.

In this way, by displaying the clinical test values with distinction as to the location where the clinical test values were obtained, it is possible to properly grasp the efficacy and side effects of the prescribed medicine.
For example, when a medical professional measures the systolic blood pressure, the patient may become nervous and a higher blood pressure may be displayed than the actual blood pressure. Therefore, by displaying the location where the systolic blood pressure was measured, the pharmacist can understand the actual systolic blood pressure.

As described above, in this embodiment, clinical test values can be displayed with a distinction made as to where they were obtained, allowing pharmacists to properly understand the effectiveness and side effects of prescribed drugs and efficiently obtain information necessary for prescription audits of prescriptions prescribed to patients.

The present invention is not limited to the above-described embodiment, and any modifications or improvements that achieve the object of the present invention are included in the present invention.

The present invention can also be applied to a terminal device having the functional configuration shown in FIG. 3. In this case, having the functional configuration shown in FIG. 3 includes not only installing software that realizes the functional configuration in the terminal device, but also allowing the terminal device to use software installed in a specified server via a network. In other words, the present invention can also be applied to so-called ASP services that provide business applications to customers via the Internet.

In addition, in this embodiment, the laboratory test values displayed by selecting a drug are displayed based on a group based on the relationship with the selected drug, but before accepting the selection, the laboratory test values may be displayed based on the relationship with all drugs. Also, by selecting a laboratory test value item or a line on a graph, a display may be made that clearly shows the drugs that have a relationship with the selected laboratory test value. Here, a display that clearly shows the drugs may mean, for example, that only drugs that have a relationship are displayed on the display unit, or that drugs that have a relationship are displayed in a different color from other drugs, highlighting them, etc.

In addition, in this embodiment, the display area V4 displays clinical test values that are not related to the drug, but this is not limited to this. For example, the display area V4 may not be provided, and clinical test values that are not related may not be displayed.

In the present invention, the clinical test values accepted by the accepting unit 211 are not limited to which medical institution the values were acquired from. For example, the clinical test values may be acquired at a pharmacy where the display device 2 is installed, or may be acquired at a medical institution other than the pharmacy where the display device 2 is installed.
The clinical test values acquired at other medical institutions and accepted by the accepting means 211 are not limited to clinical test values obtained by a person in charge asking the patient and inputting them, but may be values accepted from other medical institutions via a network line.

The above-described series of processes can be executed by hardware or software.
In other words, the functional configuration in Fig. 3 is merely an example and is not particularly limited. That is, it is sufficient for a computer to have a function capable of executing the above-mentioned series of processes as a whole, and the type of functional block used to realize this function is not particularly limited to the example in Fig. 3.
Furthermore, one functional block may be configured as a single piece of hardware, a single piece of software, or a combination of both.

When the series of processes is executed by software, the program constituting the software is installed into a computer or the like from a network or a recording medium.
The computer may be a computer built into dedicated hardware, or may be a computer capable of executing various functions by installing various programs, such as a general-purpose personal computer.

REFERENCE SIGNS LIST 1 Administrator device 2 Display device for displaying clinical test values 3 Display 21 Control unit 22 Storage unit 23 Input unit 24 Display unit 211 Reception means 212 Extraction means 213 Grouping means 214 Display means 221 Patient DB
222 Clinical Laboratory Test Values DB
223 Package Insert DB

Claims (9)

a prescription database storing information regarding patient prescriptions;
a patient test value database storing information regarding clinical test values of patients;
an extraction means for extracting information on the clinical test values that meet a specific condition from information stored in the patient test value database based on information on the prescription of a patient who has received the prescription;
an output means for outputting information about the patient's prescription together with at least one of the clinical test values and changes in the clinical test values extracted by the extraction means;
Equipped with
The output means is an information processing device that outputs at least one of the clinical test values and changes in the clinical test values extracted by the extraction means for each drug listed on the received prescription in an output form that makes it possible to distinguish at least one of multiple types of relationships between each drug and the clinical test values extracted by the extraction means, including the effects of the drug and side effects of the drug. a grouping means for grouping the clinical test values based on the type of the relationship with the drug;
The information processing apparatus according to claim 1 , wherein the output means outputs the grouped clinical test values in a manner that allows distinction between each group. In the grouping, one of the clinical test values may be classified into different groups for each of the drugs.
The information processing device according to claim 2 . The grouping is performed by the effect of the drug and the side effects of the drug.
4. The information processing device according to claim 2 or 3. In the grouping, when the value of the clinical test value is a predetermined value, the clinical test value may be classified into a group of side effects of a drug.
The information processing device according to claim 4. the output means, in response to receiving a selection of any one of the displayed plurality of drugs, displays the clinical test value having the relationship with the selected drug and the clinical test value not having the relationship with the selected drug.
The information processing device according to claim 2 . The output means displays the clinical test values by distinguishing the locations at which the clinical test values were obtained.
The information processing device according to claim 1 . An information processing method executed by an information processing device capable of referring to a prescription database that stores information on patient prescriptions and a patient test value database that stores information on patient clinical test values, comprising:
an extraction step of extracting information on the clinical test values that meet a specific condition from information stored in the patient test value database based on information on the prescription of a patient who has received the prescription;
an output step of outputting information about the patient's prescription together with at least one of the clinical test values and changes in the clinical test values extracted in the extraction step;
Including,
In the output step, an information processing method is provided in which at least one of the clinical test values extracted in the extraction step and changes in the clinical test values for each drug listed on the received prescription is output in an output form that makes it possible to distinguish at least one of multiple types of relationships, including the effects of the drug and side effects of the drug, between each drug and the clinical test value extracted in the extraction step. A computer that can access a prescription database that stores information about patient prescriptions and a patient test value database that stores information about patient clinical test values,
an extraction function for extracting information on the clinical test values that meet specific conditions from the information stored in the patient test value database based on information on the prescription of a patient who has received the prescription;
an output function for outputting information about the patient's prescription together with at least one of the clinical test values and changes in the clinical test values extracted by the extraction function;
Realize this,
The output function is a program that outputs, for each drug listed on the received prescription, at least one of the clinical test values and changes in the clinical test values extracted by the extraction function, in an output form that makes it possible to distinguish at least one of multiple types of relationships between each of the drugs and the clinical test values extracted by the extraction function, including the effects of the drug and the side effects of the drug.

Images